SimpleHealth Acquires Emme
February 16, 2022
SimpleHealth has acquired Emme, a healthcare technology company known for its Emme Smart Birth Control System, to accelerate its digital technology and expand connected reproductive care offerings. The deal brings Emme’s device and app capabilities into SimpleHealth’s telehealth and prescription delivery platform and names Emme co-founder Amanda French as SimpleHealth’s Chief Innovation Officer.
- Buyers
- SimpleHealth
- Targets
- Emme
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
New Mountain Capital Acquires Emmes from Behrman Capital
June 21, 2022
Healthcare Services
Affiliates of New Mountain Capital have agreed to acquire Emmes, a global clinical research organization, from Behrman Capital and Emmes' other investors. The transaction, expected to close in early July 2022, positions Emmes for its next phase of growth with additional investment to expand its commercial, global and eClinical technology capabilities; terms were not disclosed.
-
Emmes Acquires Essex Management
March 21, 2023
Healthcare Services
Emmes, a global full-service clinical research organization, acquired Essex Management, a bioinformatics and health information technology consultancy, to enhance Emmes' data, bioinformatics and HIT capabilities. The acquisition adds more than 100 employees and expands Emmes' ability to serve government, academic and biopharma clients, including continued support for the National Cancer Institute.
-
Flywire Acquires Simplee to Expand Healthcare Payments and Patient Engagement
February 13, 2020
Payments & Fintech
Flywire, a Boston-based vertical payments company, has acquired Simplee, a healthcare technology platform that provides patient financial engagement and payment solutions. The deal strengthens Flywire’s healthcare payments capabilities and follows a $120 million Series E round led by Goldman Sachs to support Flywire’s multi-vertical growth strategy.
-
Emmes Acquires Casimir to Strengthen Rare Disease Research Capabilities
May 10, 2022
Healthcare Services
Emmes, a portfolio company of Behrman Capital, has acquired Casimir, a Plymouth, Massachusetts–based CRO specializing in rare disease outcome measures and virtual/remote assessments. The add-on expands Emmes' rare disease center of excellence and brings Casimir's clinical outcomes technology and expertise into Emmes' global service offerings; terms were not disclosed.
-
Emmes Acquires Neox
December 30, 2020
Healthcare Services
The Emmes Company, a Behrman Capital portfolio company, has acquired Prague-headquartered CRO Neox S.R.O., an add-on that expands Emmes' BioPharma capabilities and Central/Eastern European presence. Financial terms were not disclosed; Neox brings over 150 employees and operations across multiple European countries, and founders Pavel and Petr Marek will remain in leadership roles.
-
Emmes Acquires Clinical Edge
September 28, 2022
Healthcare Services
Emmes, a global full-service clinical research organization, has acquired Clinical Edge, a Milwaukee-based provider of visual function examiner training and certification for ophthalmic clinical trials. The deal combines Clinical Edge with Emmes' Optym ophthalmology unit (rebranded OptymEdge), expanding Emmes' ophthalmology certification capabilities and geographic reach across the U.S., Europe and Asia.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.